Scott Pattison, DPM
Foot & Ankle Surgery · Georgetown, TXNPI 1023047909
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 57.6% of the total. Reporting peaked in 2022 at $2,227 and has fallen 85.4% since, to $325 in 2025.
Across 97 payments — averaging $62.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Smith+Nephew$981
- Arthrosurface Incorporated$428
- Osiris Therapeutics Inc.$186
- Stryker$137
- DJO, LLC$123
- plus $708 from 19 others
What the payments were for
- Travel & lodging$2,96549%
- Food & beverage$2,85247%
- Education$2294%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 24 | $3,483 |
| Smith+Nephew | 30 | $981 |
| Arthrosurface Incorporated | 1 | $428 |
| Osiris Therapeutics Inc. | 4 | $186 |
| Stryker | 4 | $137 |
| DJO, LLC | 3 | $123 |
| Kerecis Limited | 2 | $120 |
| Paratek Pharmaceuticals, Inc. | 6 | $100 |
| Integra Lifesciences Corporation | 4 | $63 |
| Averitas Pharma Inc. | 1 | $48 |
| Ossio Inc | 1 | $47 |
| Melinta Therapeutics, LLC | 2 | $45 |
| Nevro Corp. | 2 | $37 |
| Mimedx Group, Inc. | 1 | $35 |
| Organogenesis Inc. | 2 | $34 |
| Anika Therapeutics, Inc. | 1 | $31 |
| Abbott | 1 | $25 |
| GRT US Holding, Inc. | 1 | $24 |
| Dynasplint Systems Inc. | 1 | $21 |
| Amgen | 1 | $19 |
| IBSA Pharma Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Globus Medical | 1 | $14 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$3,142
- Kerecis SurgiClose$467
- HemiCAP MTP Resurfacing$428
- Grafix$264
- Stravix$241
- Grafix PL PRIME$240
- Grafix PRIME$122
- Grafix CORE$122
- Grafix XC$122
- GrafixPL$119
- Kerecis GraftGuide$117
How this compares
$6,046 in reported general payments places this provider in the 60th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $332 |
| Terbinafine Hcl | 16 | $296 |
| Doxycycline Hyclate | 18 | $195 |
| Mupirocin | 28 | $179 |
| Ammonium Lactate | 12 | $87 |
| Methylprednisolone | 15 | $78 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Georgetown
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.